Group One Trading, L.P. Glycomimetics Inc Transaction History

Group One Trading, L.P.

  • $2.2 Billion
  • Q1 2025

A detailed history of Group One Trading, L.P. transactions in Glycomimetics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 24,425 shares of GLYC stock, worth $5,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,425
Previous 23,369 4.52%
Holding current value
$5,129
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$0.21 - $0.33 $221 - $348
1,056 Added 4.52%
24,425 $5,000
Q4 2024

Feb 14, 2025
SELL
$0.14 - $0.54 $2,050 - $7,909
-14,648 Reduced 38.53%
23,369 $5,000
Q3 2024

Nov 14, 2024
SELL
$0.16 - $0.32 $4,386 - $8,773
-27,416 Reduced 41.9%
38,017 $6,000
Q2 2024

Aug 14, 2024
BUY
$0.24 - $3.04 $8,820 - $111,732
36,754 Added 128.16%
65,433 $18,000
Q1 2024

May 10, 2024
SELL
$2.55 - $3.49 $6,563 - $8,983
-2,574 Reduced 8.24%
28,679 $86,000
Q4 2023

Feb 14, 2024
BUY
$1.13 - $2.54 $3,222 - $7,244
2,852 Added 10.04%
31,253 $73,000
Q3 2023

Nov 09, 2023
SELL
$1.29 - $1.73 $33,202 - $44,526
-25,738 Reduced 47.54%
28,401 $42,000
Q2 2023

Aug 09, 2023
BUY
$1.21 - $2.08 $65,508 - $112,609
54,139 New
54,139 $94,000
Q4 2022

Feb 09, 2023
BUY
$0.57 - $3.03 $7,315 - $38,887
12,834 New
12,834 $38,000
Q2 2021

Aug 10, 2021
SELL
$2.16 - $3.18 $76,073 - $111,996
-35,219 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$2.89 - $4.22 $10,039 - $14,660
3,474 Added 10.94%
35,219 $106,000
Q4 2020

Feb 10, 2021
SELL
$2.69 - $4.24 $33,775 - $53,237
-12,556 Reduced 28.34%
31,745 $119,000
Q3 2020

Nov 12, 2020
BUY
$3.07 - $5.0 $136,004 - $221,505
44,301 New
44,301 $136,000
Q4 2019

Feb 10, 2020
SELL
$4.03 - $6.5 $5,025 - $8,105
-1,247 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$2.8 - $12.85 $691 - $3,173
247 Added 24.7%
1,247 $5,000
Q2 2019

Aug 09, 2019
BUY
$10.6 - $13.12 $10,600 - $13,120
1,000 New
1,000 $12,000
Q3 2018

Nov 08, 2018
SELL
$13.7 - $17.12 $23,331 - $29,155
-1,703 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$14.63 - $19.19 $4,389 - $5,757
300 Added 21.38%
1,703 $27,000
Q1 2018

May 11, 2018
SELL
$16.06 - $25.35 $88,859 - $140,261
-5,533 Reduced 79.77%
1,403 $23,000
Q4 2017

Feb 09, 2018
BUY
$10.51 - $17.22 $72,897 - $119,437
6,936
6,936 $116,000

Others Institutions Holding GLYC

# of Institutions
38
Shares Held
30.8M
Call Options Held
80.9K
Put Options Held
20.8K
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $11M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email